Clinical trials
Withdrawn Phase 1/2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 1 |
| Guangzhou Bio-gene Technology Co., Ltd | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| M.D. Anderson Cancer Center | 1 |
| Princess Maxima Center for Pediatric Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Burkitt Lymphoma | 2 |
| Leukemia | 2 |
| Leukemia, Biphenotypic, Acute | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Blast Crisis | 1 |
| Congenital Abnormalities | 1 |
| Hodgkin Disease | 1 |
| Immunoblastic Lymphadenopathy | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.